First report of efficacy and safety from the phase II study SECOMBIT (SEquential COMBo Immuno and Targeted therapy study)

被引：19

作者：

Ascierto, P. A. ^{[1
]}

Mandala, M. ^{[2
]}

Ferrucci, P. F. ^{[3
]}

Rutkowski, P. ^{[4
]}

Guidoboni, M. ^{[5
]}

Arance Fernandez, A. M. ^{[6
]}

Ferraresi, V. ^{[7
]}

Maiello, E. ^{[8
]}

Guida, M. ^{[9
]}

Del Vecchio, M. ^{[10
]}

Fierro, M. T. ^{[11
]}

Queirolo, P. ^{[12
]}

Lebbe, C. ^{[13
,14
]}

Helgadottir, H. ^{[15
,16
]}

Melero, I. ^{[17
]}

Palmieri, G. ^{[18
]}

Giannarelli, D. ^{[19
]}

Grimaldi, A. M. ^{[20
]}

Dummer, R. ^{[21
,22
]}

Sileni, V. Chiarion ^{[23
]}

机构：

[1] Ist Nazl Tumori IRCCS Fdn Pascale, Melanoma Canc Immunotherapy & Dev Therapeut, Naples, Italy

[2] Papa Giovanni XXIII Canc Ctr Hosp, Dept Oncol & Haematol, Bergamo, Italy

[3] European Inst Oncol, IRCCS, Dept Expt Oncol, Canc Biotherapy Unit, Milan, Italy

[4] Maria Skotodowska Curie Natl Res Inst Oncol Canc, Dept Soft Tissue Bone Sarcoma & Melanoma, Warsaw, Poland

[5] Ist Tumori Romagna IRST, Immunotherapy & Cell Therapy Unit, Meldola, Italy

[6] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain

[7] Ist Nazl Tumori Regina Elena, Div Oncol Med 1, Rome, Italy

[8] IRCCS Fdn Casa Sollievo Sofferenza, Dept Haematol & Oncol, San Giovanni Rotondo, Italy

[9] IRCCS Ist Nazl Tumori Giovanni Paolo II, Melanoma & Rare Tumors Unit, Bari, Italy

[10] Ist Nazl Tumori Milano Fdn IRCCS, Dept Med Oncol & Hematol, Unit Melanoma Med Oncol, Milan, Italy

[11] Univ Turin, Dermatol Clin, Dept Med Sci, Turin, Italy

[12] IRCCS AOU San Martino, IST Ist Nazl Ric Canc, Skin Canc Unit, Genoa, Italy

[13] Univ Paris Diderot, INSERM, U976, Dermatol, Paris, France

[14] St Louis Hosp, AP HP, Dermatol & CIC, Paris, France

[15] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden

[16] Karolinska Univ Hosp Solna, Stockholm, Sweden

[17] Clin Univ Navarra, Dept Immunol & Immunotherapy, Pamplona, Spain

[18] Ctr Nazl Ric, Unit Canc Genet, Sassari, Italy

[19] IFO Ist Nazl Tumori Regina Elena, Unita Biostat, Rome, Italy

[20] Ist Nazl Tumori IRCCS Fdn Pascale, Dept Melanoma Canc Immunotherapy & Dev Therapeut, Naples, Italy

[21] Univ Hosp Zurich, Skin Canc Ctr, Dept Dermatol, Zurich, Switzerland

[22] Univ Zurich, Zurich, Switzerland

[23] Veneto Oncol Inst IRCCS, Dept Expt & Clin Oncol, Melanoma Canc Unit, Padua, Italy

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷

关键词：

D O I：

10.1016/j.annonc.2020.08.2275

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA45

引用

页码：S1173 / S1174

页数：2